DNA

SetupConviction 66LongHealthcareScan · Fri, Jun 26, 2026

Symmetrical triangleBullish engulfingtriangle

DNA$10.23+6.90%

ResistanceSupportVol 14Insider sell

Vol MA14 1.12M

Mar 27Apr 15May 4May 20Jun 9Jun 26

WSB mentions · 24h changelatest +200.00%· 3 mentions

Mar 27Apr 15May 4May 20Jun 9Jun 26

Trade plan

LongReward : Risk0.93

Entry

10.44

Risk

Stop

7.77

-25.6% to stop

Reward

Target 1

12.93

+23.8% to target

Stretch

Target 2

15.41

+47.5% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Ginkgo Bioworks Holdings, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.ginkgobioworks.com ↗

Price10.23

Change+6.90%

Gap-1.31%

Rel volume1.87×

Avg volume1.4M

Avg $ vol12.52M

SMA 208.78

SMA 508.58

SMA 2009.33

Price vs 50+19.23%

Price vs 200+9.59%

MA stackmixed

50/200 cross—

Supertrendup · 7.65

RSI (14)66

MACD hist0.17

MACD crossbull · 5d

Stoch %K / %D92 / 78

ADX (14)26

+DI / −DI30 / 11

RSI divergence—

MACD divergence—

ATR %+7.49%

ADR %8.63%

52w high16.14

52w low5.48

From 52w high-36.62%

Above 52w low+86.68%

New 52w highNo

SqueezeOff

Bollinger width29.82%

%B1.05

Donchian pos89.66%

Donchian high10.53

Donchian low7.63

AVWAP (52w high)9.16

vs AVWAP high+11.67%

AVWAP (52w low)8.42

vs AVWAP low+21.44%

OBV trendUp

Chaikin MF (20)-0.03

Today vs 20d1.87×

Avg vol (14d)1.12M

Avg vol (20d)1.4M

Avg $ vol (20d)12.52M

Market cap—

RS 3m (vs SPY)+18.23%

RS 6m (vs SPY)+1.65%

RS line new highNo

Trend template4/8

Technical rank79.4

1 week+11.56%

1 month+17.45%

3 months+59.59%

6 months+16.65%

1 year+9.76%

YTD+17.59%

P/E-1.89

P/B1.33

P/S3.47

P/FCF-3.30

EPS-5.64

Div yield—

ROE-70.58%

ROA-30.28%

Debt/Eq—

Current5.15

EV/EBITDA-1.74

Gross margin—

Net margin-183.81%

Rev growth-25.06%

EPS growth42.83%

Price target12.00

Target upside25.46%

Analyst ratingBuy

Institutional66.18%

Ent. value445.92M

Revenue19.47M

Net income-82.59M

Gross profit—

Free cash flow-178.72M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out53.36M

Employees485

ListedMon, Apr 19, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction66 / 100

Pattern quality50%

Tech rank79.4 / 100

Group rank50 / 100

Status laneSetting up

Setup directionLong

Pattern familyTriangle

Resistance10.44

Support7.96

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 18 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
May 29
1 scan
→
Setting up
Jun 24 – Jun 26
2 scans

Congress activity

Disclosed STOCK Act trades in DNA

All disclosures →

No recent disclosed trades by Congress in DNA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNA · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Coen Steven P. See remarks · Class A Common Stock · 2026-05-22	Sell	307	$3K	2026-05-22	2026-05-26
Coen Steven P. See remarks · Restricted Stock Units · 2026-05-21	Exercise	587	—	2026-05-21	2026-05-26
Coen Steven P. See remarks · Restricted Stock Units · 2026-05-21	Exercise	156	—	2026-05-21	2026-05-26
Coen Steven P. See remarks · Class A Common Stock · 2026-05-21	Exercise	587	—	2026-05-21	2026-05-26
Coen Steven P. See remarks · Class A Common Stock · 2026-05-21	Exercise	156	—	2026-05-21	2026-05-26
Coen Steven P. See remarks · Class A Common Stock · 2026-04-17	Sell	324	$3K	2026-04-17	2026-04-20
Coen Steven P. See remarks · Restricted Stock Units · 2026-04-16	Exercise	156	—	2026-04-16	2026-04-20
Coen Steven P. See remarks · Class A Common Stock · 2026-04-16	Exercise	587	—	2026-04-16	2026-04-20
Coen Steven P. See remarks · Class A Common Stock · 2026-04-16	Exercise	156	—	2026-04-16	2026-04-20
Coen Steven P. See remarks · Restricted Stock Units · 2026-04-16	Exercise	587	—	2026-04-16	2026-04-20

SEC filings

EDGAR filings in DNA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.